Embold Health named to the 2022 CB Insights’ Digital Health 150 List

December 7, 2022
5 min read
Share this post

Embold Health recognized for achievements in interoperability, data, and analytics

NEW YORK, December 7, 2022 -- CB Insights today named Embold Health to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.

"From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this year’s Digital Health 150 winners are transforming the future of healthcare with digital technology,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s winners.”

Embold Health’s physician performance rankings offers employers, employees, health plans and health systems real-time, transparent and actionable data on provider quality through practice pattern and appropriateness metrics that are visible to all healthcare stakeholders. The result is higher quality care from providers, more appropriate care for members, and lower overall costs for employers.

“We're honored that Embold Health has earned a place on CB Insights' 2022 Digital Health List,” said Dr. Daniel Stein, Embold Health CEO and Founder. “Our team is on a mission to improve healthcare for all, and this accomplishment validates our position as the gold standard in actionable and defensible doctor performance ratings.  We are proud to be recognized for the meaningful impact we have made on advancing and improving the quality of healthcare delivered across the entire care continuum.”

Utilizing the CB Insights platform, the research team selected these 150 winners from a pool of over 13,000 private companies, including applicants and nominees. They were chosen based on factors including R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. The research team also reviewed over 3,000 Analyst Briefings submitted by applicants.

About Embold Health:

We are a doctor-led, doctor-founded group of healthcare advocates leading a community that wants to improve healthcare for all. Through rigorous data analytics, we have developed the gold standard indefensible and actionable doctor ratings that are completely visible to all health care stakeholders. The result is higher quality care from providers, more appropriate care for members, and lower overall costs for employers. Visit www.emboldhealth.com to learn more.

About the 2022 Digital Health 150:

Equity funding and deals: Since 2017, this year's Digital Health 150 winners have raised around $5.6B in equity funding across 378 deals. This includes approximately $1.6B raised across 85 deals in 2022 YTD alone. Winners in this year's Digital Health 150 span 18 countries across 5 continents.

See the entire Digital Health 150 list here: The Digital Health 150: The most promising digital health companies of 2022 - CB Insights Research

For media inquiries: marketing@emboldhealth.com

For additional information: sales@emboldhealth.com


Measure what matters

This technical whitepaper outlines how the Embold methodology measures quality at the physician level.

Higher quality and affordable care

This ebook highlights how employers can leverage the power of provider-level quality data.

Save on healthcare spending

This overview explores how we use data to bridge the gap between members and high-quality healthcare.